Gene · 5819
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Copper homeostasis-associated gene PRNP regulates ferroptosis and immune infiltration in breast cancer. | PLoS One | 2023 | 37535656 | PubTator, text mining | PubMed |
| Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer. | Front Oncol | 2023 | 37519808 | PubTator, text mining | PubMed |
| Innate Immunity in Cancer Biology and Therapy. | Int J Mol Sci | 2023 | 37510993 | PubTator, text mining | PubMed |
| Machine-learning and combined analysis of single-cell and bulk-RNA sequencing identified a DC gene signature to predict prognosis and immunotherapy response for patients with lung adenocarcinoma. | J Cancer Res Clin Oncol | 2023 | 37507593 | PubTator, text mining | PubMed |
| TIGIT, a novel immune checkpoint therapy for melanoma. | Cell Death Dis | 2023 | 37495610 | PubTator, text mining | PubMed |
| The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition. | Ther Adv Med Oncol | 2023 | 37484526 | PubTator, text mining | PubMed |
| Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors. | Front Immunol | 2023 | 37483600 | PubTator, text mining | PubMed |
| Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients. | Eur J Med Res | 2023 | 37480146 | PubTator, text mining | PubMed |
| Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review. | J Cancer | 2023 | 37476189 | PubTator, text mining | PubMed |
| Defining the role of natural killer cells in COVID-19. | Nat Immunol | 2023 | 37460639 | PubTator, text mining | PubMed |
| The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression. | J Alzheimers Dis | 2023 | 37458041 | PubTator, text mining | PubMed |
| Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma. | Front Immunol | 2023 | 37457742 | PubTator, text mining | PubMed |
| In vitro models to study natural killer cell dynamics in the tumor microenvironment. | Front Immunol | 2023 | 37457703 | PubTator, text mining | PubMed |
| APOE Locus-Associated Mitochondrial Function and Its Implication in Alzheimer's Disease and Aging. | Int J Mol Sci | 2023 | 37445616 | PubTator, text mining | PubMed |
| Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta. | Cancers (Basel) | 2023 | 37444427 | PubTator, text mining | PubMed |
| Complex interactions of cellular players in chronic Graft-versus-Host Disease. | Front Immunol | 2023 | 37435079 | PubTator, text mining | PubMed |
| Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells. | Front Immunol | 2023 | 37435067 | PubTator, text mining | PubMed |
| AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation. | Front Immunol | 2023 | 37435061 | PubTator, text mining | PubMed |
| An integrative bioinformatics investigation and experimental validation of chromobox family in diffuse large B-cell lymphoma. | BMC Cancer | 2023 | 37430195 | PubTator, text mining | PubMed |
| Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy. | Front Oncol | 2023 | 37427115 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5819/papers?page=19